非肿瘤适应证不断拓展的新时代下 CAR-T 细胞 治疗的肝脏效应、潜在药物性肝损伤及其他肝脏安全性考量：文献综述与专家共识

Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the

CAR-T 细胞与过继性 T 细胞疗法在淋巴及实体器官恶性肿瘤中的综述

A Review of CAR T Cells and Adoptive T-Cell Therapies in Lymphoid and Solid Organ Malignancies.

免疫检查点抑制剂与 CAR-T 细胞治疗联合或序贯治疗血液系统恶性肿瘤：系统综述

Combined or Sequential Treatment with Immune Checkpoint Inhibitors and Car-T Cell Therapies for the Management of Haematological Malignancies: A Syste

实体瘤中的 CAR-T 细胞治疗：当前临床试验综述

CAR T cell therapy in solid tumors: A review of current clinical trials.

年龄、种族与族裔同 B 细胞恶性肿瘤儿童和成人 CAR-T 治疗可及性、缓解及毒性的关联：综述

Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a re

已获批细胞疗法和双特异性抗体在实体瘤中的疗效与安全性：现状

Efficacy and safety of approved cellular therapies and bispecific antibodies in solid tumors: the current state.

释放 CAR-T 细胞治疗的潜力：血液肿瘤与实体瘤治疗中的进展、挑战与未来方向

Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.

CAR-T 治疗血液肿瘤与实体瘤的当前进展与挑战

Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors.

尽管 CAR-T 疗法已经彻底改变了某些血液系统恶性肿瘤的治疗，但将其成功扩展到实体瘤仍面临重大障碍。持续的研究努力，聚焦于提高 CAR-T 细胞的疗效、安全性和可及性，对于在广泛癌症类型中充分释放这种创新免疫治疗方法的潜力至关重要。

中枢神经系统血液系统恶性肿瘤的紧急和急诊放疗：文献综述与实践方法

Urgent and emergent radiotherapy for hematologic malignancies of the central nervous system: a review of the literature and practical approach.

RT 是实现血液系统恶性肿瘤快速缓解的有力工具，因此在紧急神经系统情况下应早期考虑。全面的检查和与多学科团队的讨论对于将 RT 最佳地整合到其他 CNS 穿透性治疗的背景下至关重要。在新疗法的背景下，进一步明确 RT 靶区体积的工作是必要的。

CAR-T 细胞的基本概念与适应症

Basic Concepts and Indications of CAR T Cells.